Advertisement

Index by author

September 01, 1996; Volume 24,Issue 9

A

  1. Allen, E M

    1. Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

  2. Angelin, B

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

  3. Arvidsson, T

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

  4. Askemark, Y

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

B

  1. Bend, J R

    1. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
      C J Sinal and J R Bend
      Drug Metabolism and Disposition September 1996, 24 (9) 996-1001;

  2. Bort, R

    1. Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;

  3. Bredberg, E

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

  4. Burke, M D

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

  5. Bush, E

    1. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;

C

  1. Carrasco, E

    1. Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;

  2. Castell, J V

    1. Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;

  3. Czerwinski, M

    1. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
      M Czerwinski, J P Gibbs and J T Slattery
      Drug Metabolism and Disposition September 1996, 24 (9) 1015-1019;

D

  1. Darbyshire, J F

    1. Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

  2. Davis, C B

    1. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;

  3. Dean, J M

    1. Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

E

  1. Ekins, S

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

  2. Ekström, G

    1. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
      G Ekström and U B Gunnarsson
      Drug Metabolism and Disposition September 1996, 24 (9) 955-961;

  3. Elofsson, S

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

  4. Engeset, J

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

  5. Evans, A M

    1. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

F

  1. Fairchild, B A

    1. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

  2. Feierman, D E

    1. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
      D E Feierman and J M Lasker
      Drug Metabolism and Disposition September 1996, 24 (9) 932-939;

G

  1. Garver, E M

    1. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;

  2. Ghosal, A

    1. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;

  3. Gibbs, J P

    1. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
      M Czerwinski, J P Gibbs and J T Slattery
      Drug Metabolism and Disposition September 1996, 24 (9) 1015-1019;

  4. Gómez-Lechón, M J

    1. Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;

  5. Grogan, J

    1. Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

  6. Guenthner, T M

    1. Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1996, 24 (9) 1020-1027;

  7. Gunnarsson, U B

    1. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
      G Ekström and U B Gunnarsson
      Drug Metabolism and Disposition September 1996, 24 (9) 955-961;

H

  1. Halldin, M M

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

  2. Hawksworth, G M

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

  3. Heyn, H

    1. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
      H Heyn, R B White and J C Stevens
      Drug Metabolism and Disposition September 1996, 24 (9) 948-954;

I

  1. Iyer, K R

    1. Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

K

  1. Kapetanovic, I M

    1. Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;

  2. Kattnig, M J

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;

  3. Kharasch, E D

    1. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
      D K Spracklin, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition September 1996, 24 (9) 976-983;

  4. Korzekwa, K R

    1. Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

  5. Kupferberg, H J

    1. Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;

  6. Kwok, D C

    1. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;

L

  1. Larsen-Su, S

    1. Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine.
      S Larsen-Su and D E Williams
      Drug Metabolism and Disposition September 1996, 24 (9) 927-931;

  2. Lasker, J M

    1. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
      D E Feierman and J M Lasker
      Drug Metabolism and Disposition September 1996, 24 (9) 932-939;

  3. Liebler, D C

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;

  4. Luo, G

    1. Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1996, 24 (9) 1020-1027;

M

  1. Marchant, N C

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

  2. Mayersohn, M

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;

  3. McNeilly, P J

    1. Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;

  4. Moore, D

    1. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;

  5. Murray, G I

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

N

  1. Nation, R L

    1. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

P

  1. Pappas, J B

    1. Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

  2. Pillai, U A

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;

  3. Ponsoda, X

    1. Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition September 1996, 24 (9) 969-975;

R

  1. Rowin, M

    1. Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

S

  1. Sallustio, B C

    1. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

  2. Satoh, H

    1. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;

  3. Shanahan, K

    1. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
      B C Sallustio, B A Fairchild, K Shanahan, A M Evans and R L Nation
      Drug Metabolism and Disposition September 1996, 24 (9) 984-989;

  4. Sinal, C J

    1. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
      C J Sinal and J R Bend
      Drug Metabolism and Disposition September 1996, 24 (9) 996-1001;

  5. Sipes, I G

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;

  6. Slattery, J T

    1. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
      M Czerwinski, J P Gibbs and J T Slattery
      Drug Metabolism and Disposition September 1996, 24 (9) 1015-1019;

  7. Smith, R L

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;

  8. Spracklin, D K

    1. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
      D K Spracklin, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition September 1996, 24 (9) 976-983;

  9. Stevens, J C

    1. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
      H Heyn, R B White and J C Stevens
      Drug Metabolism and Disposition September 1996, 24 (9) 948-954;

  10. Strong, J M

    1. Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;

T

  1. Thomas, P E

    1. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
      A Ghosal, H Satoh, P E Thomas, E Bush and D Moore
      Drug Metabolism and Disposition September 1996, 24 (9) 940-947;

  2. Thummel, K E

    1. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
      D K Spracklin, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition September 1996, 24 (9) 976-983;

  3. Torchin, C D

    1. Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
      C D Torchin, P J McNeilly, I M Kapetanovic, J M Strong and H J Kupferberg
      Drug Metabolism and Disposition September 1996, 24 (9) 1002-1008;

  4. Trager, W F

    1. Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450.
      J F Darbyshire, K R Iyer, J Grogan, K R Korzekwa and W F Trager
      Drug Metabolism and Disposition September 1996, 24 (9) 1038-1045;

U

  1. Urbanski, J J

    1. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
      C B Davis, E M Garver, D C Kwok and J J Urbanski
      Drug Metabolism and Disposition September 1996, 24 (9) 1032-1037;

V

  1. Vernon, D D

    1. Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
      E M Allen, M Rowin, J B Pappas, D D Vernon and J M Dean
      Drug Metabolism and Disposition September 1996, 24 (9) 1028-1031;

W

  1. White, R B

    1. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
      H Heyn, R B White and J C Stevens
      Drug Metabolism and Disposition September 1996, 24 (9) 948-954;

  2. Widman, M

    1. Metabolism and excretion of ropivacaine in humans.
      M M Halldin, E Bredberg, B Angelin, T Arvidsson, Y Askemark, S Elofsson and M Widman
      Drug Metabolism and Disposition September 1996, 24 (9) 962-968;

  3. Williams, D E

    1. Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine.
      S Larsen-Su and D E Williams
      Drug Metabolism and Disposition September 1996, 24 (9) 927-931;

  4. Williams, J A

    1. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
      S Ekins, J A Williams, G I Murray, M D Burke, N C Marchant, J Engeset and G M Hawksworth
      Drug Metabolism and Disposition September 1996, 24 (9) 990-995;

Z

  1. Ziegler, T L

    1. Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.
      T L Ziegler, U A Pillai, R L Smith, M J Kattnig, D C Liebler, M Mayersohn and I G Sipes
      Drug Metabolism and Disposition September 1996, 24 (9) 1009-1014;
Back to top

In this issue